McCormick Proposed Doubling NIH Research Budget
The proposal aims to bolster scientific research and address rising national health costs.
Updated on Sept. 23, 2026 in Healthcare
Live Poll
Should the federal government double its investment in scientific research to drive medical innovation?
Senator Dave McCormick has proposed legislation to double the National Institutes of Health budget within five years. The initiative seeks to revitalize federal research spending, which has significantly declined as a percentage of GDP since 1964.
Why it matters
McCormick argues that foundational science requires public investment because private capital cannot sustain early-stage research. He believes this increased funding will ultimately help reduce the nation's $5.3 trillion annual health bill.
The NIH currently operates on a $48 billion annual budget that has shrunk by more than 10% since 2003 when adjusted for inflation. Meanwhile, China's R&D spending reached parity with U.S. levels in 2024, up from 36% of U.S. levels in 2008.
The players
Dave McCormick
He is a United States Senator who has prioritized federal research funding and financial transparency in academic science.
National Institutes of Health
This is the primary federal agency responsible for biomedical and public health research in the United States.
Children's Hospital of Philadelphia
It is a pediatric research and clinical institution that faced significant disruptions due to recent federal grant cancellations.
University of Pittsburgh
This major research university is a primary recipient of federal funding and was impacted by the termination of midstream research grants.
The details
The plan includes the Sunshine for Researchers Act, requiring financial disclosure of industry ties for recipients of federal funds, and the NIH Mentorship Modernization Act to improve scientist retention. These measures follow recent disruptions where the Trump administration canceled nearly 1,400 midstream research grants, costing taxpayers $1.3 billion.
Timeline
The decline in inflation-adjusted NIH funding began in 2003.
China's R&D spending was 36% of U.S. levels in 2008.
China reached R&D spending parity with the U.S. in 2024.
Senator McCormick visited the University of Pennsylvania in March 2026.
Researchers at CHOP and Pitt were notified of grant cancellations on July 15, 2026.
Market Landscape
This proposal marks a pivot in federal research policy as the U.S. looks to regain competitive dominance against rising international R&D investment. It specifically addresses the regulatory environment for scientists following the cancellation of 1,400 grants.
The proposed funding increase could lead to more stable research environments for the 21,000 jobs sustained by NIH funding in Pennsylvania. However, researchers may face stricter compliance requirements under the proposed financial disclosure mandates.
The takeaway
The move to double NIH funding reflects an attempt to secure long-term scientific competitiveness against international rivals. Readers should watch for how new disclosure requirements might impact the administrative burden on academic researchers.
Further reading
For broader context on federal policy, visit the Healthcare section.
Live Poll
Should the federal government double its investment in scientific research to drive medical innovation?
